09:00 Fri 09 Oct 2020
OptiBiotix Health - Investor presentation
OptiBiotix Health plc
("OptiBiotix")
Investor presentation
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces that
The event will be held on Thursday,
No new price-sensitive information will be disclosed as part of the presentation.
OptiBiotix Health plc |
||
|
Contact via Walbrook below |
|
|
|
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or optibiotix@walbrookpr.com |
|
|
Mob: 07876 741 001 |
|
About OptiBiotix - www.optibiotix.com
OptiBiotix Health plc (AIM: OPTI), which was formed in
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than sixty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products. The current areas of focus for the business include obesity, cardiovascular health, diabetes, digestive health, and health and wellbeing.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE